JP2010512730A

JP2010512730A - 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ

肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ Download PDF

Info

Publication number: JP2010512730A
Authority: JP; Japan
Prior art keywords: seq; ttk; polypeptide; egfr; amino acid
Prior art date: 2006-12-13
Legal status : Withdrawn

Application number

JP2009524832A

Other languages

English (en)

Japanese (ja)

Other versions

JP2010512730A5 (enExample

Inventor

祐輔中村

弥太郎醍醐

修一中鶴

Current Assignee

Oncotherapy Science Inc

Original Assignee

Oncotherapy Science Inc

Priority date

2006-12-13

Filing date

2007-12-12

Publication date

2010-04-30

2007-12-12 Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc

2010-04-30 Publication of JP2010512730A publication Critical patent/JP2010512730A/ja

2012-01-19 Publication of JP2010512730A5 publication Critical patent/JP2010512730A5/ja

Status Withdrawn legal-status Critical Current

Links

208000020816 lung neoplasm Diseases 0.000 title claims abstract description 183
206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 179
201000005202 lung cancer Diseases 0.000 title claims abstract description 179
230000001225 therapeutic effect Effects 0.000 title description 15
239000000439 tumor marker Substances 0.000 title 1
238000000034 method Methods 0.000 claims abstract description 165
230000000694 effects Effects 0.000 claims abstract description 115
108091000080 Phosphotransferase Proteins 0.000 claims abstract description 111
102000020233 phosphotransferase Human genes 0.000 claims abstract description 111
101000659223 Homo sapiens Dual specificity protein kinase TTK Proteins 0.000 claims abstract description 64
102100036109 Dual specificity protein kinase TTK Human genes 0.000 claims abstract description 42
238000012216 screening Methods 0.000 claims abstract description 20
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims abstract 43
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims abstract 30
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims abstract 30
210000004027 cell Anatomy 0.000 claims description 291
108090000765 processed proteins & peptides Proteins 0.000 claims description 278
102000004196 processed proteins & peptides Human genes 0.000 claims description 254
229920001184 polypeptide Polymers 0.000 claims description 236
108090000623 proteins and genes Proteins 0.000 claims description 153
238000006366 phosphorylation reaction Methods 0.000 claims description 135
230000026731 phosphorylation Effects 0.000 claims description 134
230000014509 gene expression Effects 0.000 claims description 126
102000004169 proteins and genes Human genes 0.000 claims description 115
235000018102 proteins Nutrition 0.000 claims description 106
230000035772 mutation Effects 0.000 claims description 101
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 89
150000001413 amino acids Chemical group 0.000 claims description 86
150000001875 compounds Chemical class 0.000 claims description 68
235000001014 amino acid Nutrition 0.000 claims description 56
239000000203 mixture Substances 0.000 claims description 56
108091033319 polynucleotide Proteins 0.000 claims description 56
102000040430 polynucleotide Human genes 0.000 claims description 56
239000002157 polynucleotide Substances 0.000 claims description 56
108020004705 Codon Proteins 0.000 claims description 49
150000007523 nucleic acids Chemical group 0.000 claims description 43
238000012360 testing method Methods 0.000 claims description 43
230000004071 biological effect Effects 0.000 claims description 39
239000012634 fragment Substances 0.000 claims description 38
239000003153 chemical reaction reagent Substances 0.000 claims description 37
230000000692 anti-sense effect Effects 0.000 claims description 31
102000039446 nucleic acids Human genes 0.000 claims description 26
108020004707 nucleic acids Proteins 0.000 claims description 26
108091028043 Nucleic acid sequence Proteins 0.000 claims description 25
125000000539 amino acid group Chemical group 0.000 claims description 25
239000003814 drug Substances 0.000 claims description 25
239000000523 sample Substances 0.000 claims description 25
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 24
108020004999 messenger RNA Proteins 0.000 claims description 24
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 24
239000002299 complementary DNA Substances 0.000 claims description 21
210000000170 cell membrane Anatomy 0.000 claims description 17
230000004663 cell proliferation Effects 0.000 claims description 17
239000003795 chemical substances by application Substances 0.000 claims description 17
229940079593 drug Drugs 0.000 claims description 17
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 15
239000011230 binding agent Substances 0.000 claims description 15
230000007423 decrease Effects 0.000 claims description 15
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 15
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 14
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 14
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 14
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 14
210000004072 lung Anatomy 0.000 claims description 14
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 14
239000000126 substance Substances 0.000 claims description 14
239000004474 valine Substances 0.000 claims description 14
235000018417 cysteine Nutrition 0.000 claims description 13
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 13
238000004393 prognosis Methods 0.000 claims description 13
206010027476 Metastases Diseases 0.000 claims description 12
230000009401 metastasis Effects 0.000 claims description 12
239000012472 biological sample Substances 0.000 claims description 11
238000010837 poor prognosis Methods 0.000 claims description 11
125000002652 ribonucleotide group Chemical group 0.000 claims description 11
108091028664 Ribonucleotide Proteins 0.000 claims description 10
239000002336 ribonucleotide Substances 0.000 claims description 10
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 9
239000003937 drug carrier Substances 0.000 claims description 9
210000002919 epithelial cell Anatomy 0.000 claims description 7
229920000724 poly(L-arginine) polymer Polymers 0.000 claims description 5
108010011110 polyarginine Proteins 0.000 claims description 5
238000001890 transfection Methods 0.000 claims description 5
102100036976 X-ray repair cross-complementing protein 6 Human genes 0.000 claims description 4
101710124907 X-ray repair cross-complementing protein 6 Proteins 0.000 claims description 4
230000008569 process Effects 0.000 claims description 3
UKVZSPHYQJNTOU-GQJPYGCMSA-N (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoic acid Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)[C@@H](C)O)CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=CC=C1 UKVZSPHYQJNTOU-GQJPYGCMSA-N 0.000 claims description 2
108010062307 AAVALLPAVLLALLAP Proteins 0.000 claims description 2
101800002011 Amphipathic peptide Proteins 0.000 claims description 2
102100028072 Fibroblast growth factor 4 Human genes 0.000 claims description 2
108010061875 HN-1 peptide Proteins 0.000 claims description 2
101001060274 Homo sapiens Fibroblast growth factor 4 Proteins 0.000 claims description 2
108700003968 Human immunodeficiency virus 1 tat peptide (49-57) Proteins 0.000 claims description 2
108010088535 Pep-1 peptide Proteins 0.000 claims description 2
102000029797 Prion Human genes 0.000 claims description 2
108091000054 Prion Proteins 0.000 claims description 2
101710149951 Protein Tat Proteins 0.000 claims description 2
108010025307 buforin II Proteins 0.000 claims description 2
UKVZSPHYQJNTOU-IVBHRGSNSA-N chembl1240717 Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)[C@H](C)O)CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=CC=C1 UKVZSPHYQJNTOU-IVBHRGSNSA-N 0.000 claims description 2
BHONFOAYRQZPKZ-LCLOTLQISA-N chembl269478 Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=CC=C1 BHONFOAYRQZPKZ-LCLOTLQISA-N 0.000 claims description 2
108010043655 penetratin Proteins 0.000 claims description 2
MCYTYTUNNNZWOK-LCLOTLQISA-N penetratin Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=CC=C1 MCYTYTUNNNZWOK-LCLOTLQISA-N 0.000 claims description 2
230000008827 biological function Effects 0.000 claims 5
210000005265 lung cell Anatomy 0.000 claims 1
PBKWZFANFUTEPS-CWUSWOHSSA-N transportan Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CC=C(O)C=C1 PBKWZFANFUTEPS-CWUSWOHSSA-N 0.000 claims 1
108010062760 transportan Proteins 0.000 claims 1
239000008194 pharmaceutical composition Substances 0.000 abstract description 19
238000002405 diagnostic procedure Methods 0.000 abstract description 3
108060006698 EGF receptor Proteins 0.000 description 400
102000001301 EGF receptor Human genes 0.000 description 399
206010028980 Neoplasm Diseases 0.000 description 87
125000003275 alpha amino acid group Chemical group 0.000 description 65
210000001519 tissue Anatomy 0.000 description 64
108020004459 Small interfering RNA Proteins 0.000 description 63
238000011282 treatment Methods 0.000 description 58
108020004414 DNA Proteins 0.000 description 56
208000002154 non-small cell lung carcinoma Diseases 0.000 description 56
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 56
201000011510 cancer Diseases 0.000 description 53
229940024606 amino acid Drugs 0.000 description 37
102000009024 Epidermal Growth Factor Human genes 0.000 description 36
239000013598 vector Substances 0.000 description 34
125000003729 nucleotide group Chemical group 0.000 description 32
238000001262 western blot Methods 0.000 description 32
239000002773 nucleotide Substances 0.000 description 31
238000009472 formulation Methods 0.000 description 28
239000004480 active ingredient Substances 0.000 description 23
101150057353 Ttk gene Proteins 0.000 description 22
239000000284 extract Substances 0.000 description 21
102000057164 human TTK Human genes 0.000 description 21
230000002401 inhibitory effect Effects 0.000 description 21
230000004083 survival effect Effects 0.000 description 21
208000009956 adenocarcinoma Diseases 0.000 description 20
239000007788 liquid Substances 0.000 description 20
206010041823 squamous cell carcinoma Diseases 0.000 description 20
238000006467 substitution reaction Methods 0.000 description 19
101150039808 Egfr gene Proteins 0.000 description 18
238000004458 analytical method Methods 0.000 description 18
108700021358 erbB-1 Genes Proteins 0.000 description 18
238000002347 injection Methods 0.000 description 18
239000007924 injection Substances 0.000 description 18
239000013604 expression vector Substances 0.000 description 17
108020001507 fusion proteins Proteins 0.000 description 17
102000037865 fusion proteins Human genes 0.000 description 17
238000009396 hybridization Methods 0.000 description 17
238000000338 in vitro Methods 0.000 description 17
239000003826 tablet Substances 0.000 description 17
102000043136 MAP kinase family Human genes 0.000 description 16
108091054455 MAP kinase family Proteins 0.000 description 16
230000004913 activation Effects 0.000 description 16
238000001514 detection method Methods 0.000 description 16
239000000843 powder Substances 0.000 description 16
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 15
230000000295 complement effect Effects 0.000 description 15
238000011161 development Methods 0.000 description 15
230000018109 developmental process Effects 0.000 description 15
230000009368 gene silencing by RNA Effects 0.000 description 15
238000002493 microarray Methods 0.000 description 15
230000002829 reductive effect Effects 0.000 description 15
239000000758 substrate Substances 0.000 description 15
230000006870 function Effects 0.000 description 14
230000012010 growth Effects 0.000 description 14
238000010186 staining Methods 0.000 description 14
229910019142 PO4 Inorganic materials 0.000 description 13
108091081021 Sense strand Proteins 0.000 description 13
238000000021 kinase assay Methods 0.000 description 13
206010061289 metastatic neoplasm Diseases 0.000 description 13
230000004048 modification Effects 0.000 description 13
238000012986 modification Methods 0.000 description 13
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 13
239000010452 phosphate Substances 0.000 description 13
208000024891 symptom Diseases 0.000 description 13
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 12
238000000134 MTT assay Methods 0.000 description 12
239000002775 capsule Substances 0.000 description 12
238000012217 deletion Methods 0.000 description 12
230000037430 deletion Effects 0.000 description 12
230000001394 metastastic effect Effects 0.000 description 12
239000000047 product Substances 0.000 description 12
239000002904 solvent Substances 0.000 description 12
230000000638 stimulation Effects 0.000 description 12
239000000725 suspension Substances 0.000 description 12
231100000002 MTT assay Toxicity 0.000 description 11
206010041067 Small cell lung cancer Diseases 0.000 description 11
238000003556 assay Methods 0.000 description 11
230000005754 cellular signaling Effects 0.000 description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
230000002265 prevention Effects 0.000 description 11
239000000243 solution Substances 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
239000002246 antineoplastic agent Substances 0.000 description 10
239000000872 buffer Substances 0.000 description 10
230000036952 cancer formation Effects 0.000 description 10
201000010099 disease Diseases 0.000 description 10
238000005516 engineering process Methods 0.000 description 10
235000014304 histidine Nutrition 0.000 description 10
238000002991 immunohistochemical analysis Methods 0.000 description 10
208000000587 small cell lung carcinoma Diseases 0.000 description 10
208000003174 Brain Neoplasms Diseases 0.000 description 9
241001465754 Metazoa Species 0.000 description 9
241000283973 Oryctolagus cuniculus Species 0.000 description 9
230000000875 corresponding effect Effects 0.000 description 9
238000003745 diagnosis Methods 0.000 description 9
238000004519 manufacturing process Methods 0.000 description 9
239000013612 plasmid Substances 0.000 description 9
238000003752 polymerase chain reaction Methods 0.000 description 9
238000002360 preparation method Methods 0.000 description 9
239000004055 small Interfering RNA Substances 0.000 description 9
108010010803 Gelatin Proteins 0.000 description 8
102000005720 Glutathione transferase Human genes 0.000 description 8
108010070675 Glutathione transferase Proteins 0.000 description 8
241000124008 Mammalia Species 0.000 description 8
108091027967 Small hairpin RNA Proteins 0.000 description 8
230000006907 apoptotic process Effects 0.000 description 8
238000000546 chi-square test Methods 0.000 description 8
239000002552 dosage form Substances 0.000 description 8
239000008273 gelatin Substances 0.000 description 8
229920000159 gelatin Polymers 0.000 description 8
235000019322 gelatine Nutrition 0.000 description 8
235000011852 gelatine desserts Nutrition 0.000 description 8
230000009545 invasion Effects 0.000 description 8
208000003849 large cell carcinoma Diseases 0.000 description 8
108010082117 matrigel Proteins 0.000 description 8
230000001404 mediated effect Effects 0.000 description 8
230000037361 pathway Effects 0.000 description 8
230000035755 proliferation Effects 0.000 description 8
230000019491 signal transduction Effects 0.000 description 8
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 8
230000008685 targeting Effects 0.000 description 8
108091003079 Bovine Serum Albumin Proteins 0.000 description 7
238000007807 Matrigel invasion assay Methods 0.000 description 7
241000699666 Mus <mouse, genus> Species 0.000 description 7
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
229930006000 Sucrose Natural products 0.000 description 7
229940041181 antineoplastic drug Drugs 0.000 description 7
230000035578 autophosphorylation Effects 0.000 description 7
230000008901 benefit Effects 0.000 description 7
230000037396 body weight Effects 0.000 description 7
238000006243 chemical reaction Methods 0.000 description 7
230000001086 cytosolic effect Effects 0.000 description 7
239000012894 fetal calf serum Substances 0.000 description 7
BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 7
230000005764 inhibitory process Effects 0.000 description 7
230000003834 intracellular effect Effects 0.000 description 7
238000001325 log-rank test Methods 0.000 description 7
210000004962 mammalian cell Anatomy 0.000 description 7
210000004940 nucleus Anatomy 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
239000005720 sucrose Substances 0.000 description 7
230000001629 suppression Effects 0.000 description 7
239000000375 suspending agent Substances 0.000 description 7
208000010507 Adenocarcinoma of Lung Diseases 0.000 description 6
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
101710154606 Hemagglutinin Proteins 0.000 description 6
108700020796 Oncogene Proteins 0.000 description 6
101710093908 Outer capsid protein VP4 Proteins 0.000 description 6
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
101710176177 Protein A56 Proteins 0.000 description 6
102000001332 SRC Human genes 0.000 description 6
108060006706 SRC Proteins 0.000 description 6
230000010261 cell growth Effects 0.000 description 6
230000004709 cell invasion Effects 0.000 description 6
230000003833 cell viability Effects 0.000 description 6
230000003247 decreasing effect Effects 0.000 description 6
239000008187 granular material Substances 0.000 description 6
239000000185 hemagglutinin Substances 0.000 description 6
239000004615 ingredient Substances 0.000 description 6
238000003780 insertion Methods 0.000 description 6
230000037431 insertion Effects 0.000 description 6
230000003993 interaction Effects 0.000 description 6
239000000314 lubricant Substances 0.000 description 6
201000005249 lung adenocarcinoma Diseases 0.000 description 6
239000003755 preservative agent Substances 0.000 description 6
230000001737 promoting effect Effects 0.000 description 6
230000011664 signaling Effects 0.000 description 6
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 6
GFNNBHLJANVSQV-UHFFFAOYSA-N tyrphostin AG 1478 Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1NC1=CC=CC(Cl)=C1 GFNNBHLJANVSQV-UHFFFAOYSA-N 0.000 description 6
102100026205 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 Human genes 0.000 description 5
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
241000283690 Bos taurus Species 0.000 description 5
229920002261 Corn starch Polymers 0.000 description 5
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 5
241000282412 Homo Species 0.000 description 5
101000691599 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 Proteins 0.000 description 5
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
241000699670 Mus sp. Species 0.000 description 5
108700026244 Open Reading Frames Proteins 0.000 description 5
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 5
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 5
229920001615 Tragacanth Polymers 0.000 description 5
239000000654 additive Substances 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
238000007796 conventional method Methods 0.000 description 5
239000008120 corn starch Substances 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
238000003018 immunoassay Methods 0.000 description 5
238000010185 immunofluorescence analysis Methods 0.000 description 5
238000001727 in vivo Methods 0.000 description 5
238000011534 incubation Methods 0.000 description 5
238000001802 infusion Methods 0.000 description 5
239000003112 inhibitor Substances 0.000 description 5
238000007918 intramuscular administration Methods 0.000 description 5
238000001990 intravenous administration Methods 0.000 description 5
239000008101 lactose Substances 0.000 description 5
239000000546 pharmaceutical excipient Substances 0.000 description 5
239000012071 phase Substances 0.000 description 5
230000001105 regulatory effect Effects 0.000 description 5
239000007921 spray Substances 0.000 description 5
238000002560 therapeutic procedure Methods 0.000 description 5
230000014616 translation Effects 0.000 description 5
230000004614 tumor growth Effects 0.000 description 5
241000416162 Astragalus gummifer Species 0.000 description 4
241000282472 Canis lupus familiaris Species 0.000 description 4
208000005623 Carcinogenesis Diseases 0.000 description 4
102000053602 DNA Human genes 0.000 description 4
241000282326 Felis catus Species 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
108010001336 Horseradish Peroxidase Proteins 0.000 description 4
235000010643 Leucaena leucocephala Nutrition 0.000 description 4
240000007472 Leucaena leucocephala Species 0.000 description 4
108060001084 Luciferase Proteins 0.000 description 4
239000005089 Luciferase Substances 0.000 description 4
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 4
238000000636 Northern blotting Methods 0.000 description 4
108091034117 Oligonucleotide Proteins 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
239000002202 Polyethylene glycol Substances 0.000 description 4
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 4
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 4
241000700159 Rattus Species 0.000 description 4
239000000443 aerosol Substances 0.000 description 4
238000001042 affinity chromatography Methods 0.000 description 4
239000000427 antigen Substances 0.000 description 4
108091007433 antigens Proteins 0.000 description 4
102000036639 antigens Human genes 0.000 description 4
239000003963 antioxidant agent Substances 0.000 description 4
235000006708 antioxidants Nutrition 0.000 description 4
238000013459 approach Methods 0.000 description 4
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 4
235000019445 benzyl alcohol Nutrition 0.000 description 4
SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
231100000504 carcinogenesis Toxicity 0.000 description 4
239000000969 carrier Substances 0.000 description 4
-1 cartridges Substances 0.000 description 4
210000003855 cell nucleus Anatomy 0.000 description 4
238000007385 chemical modification Methods 0.000 description 4
210000004748 cultured cell Anatomy 0.000 description 4
210000000805 cytoplasm Anatomy 0.000 description 4
239000002270 dispersing agent Substances 0.000 description 4
239000003995 emulsifying agent Substances 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
230000004927 fusion Effects 0.000 description 4
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
238000003119 immunoblot Methods 0.000 description 4
238000001114 immunoprecipitation Methods 0.000 description 4
206010022000 influenza Diseases 0.000 description 4
238000010253 intravenous injection Methods 0.000 description 4
239000003446 ligand Substances 0.000 description 4
239000002502 liposome Substances 0.000 description 4
239000002609 medium Substances 0.000 description 4
239000012528 membrane Substances 0.000 description 4
238000010208 microarray analysis Methods 0.000 description 4
238000000465 moulding Methods 0.000 description 4
210000000056 organ Anatomy 0.000 description 4
230000002018 overexpression Effects 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
238000010647 peptide synthesis reaction Methods 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
239000011775 sodium fluoride Substances 0.000 description 4
235000013024 sodium fluoride Nutrition 0.000 description 4
239000007787 solid Substances 0.000 description 4
239000003381 stabilizer Substances 0.000 description 4
238000010561 standard procedure Methods 0.000 description 4
238000007920 subcutaneous administration Methods 0.000 description 4
238000011144 upstream manufacturing Methods 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
108010051109 Cell-Penetrating Peptides Proteins 0.000 description 3
102000020313 Cell-Penetrating Peptides Human genes 0.000 description 3
241000282693 Cercopithecidae Species 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
230000004544 DNA amplification Effects 0.000 description 3
238000002965 ELISA Methods 0.000 description 3
238000000729 Fisher's exact test Methods 0.000 description 3
238000010824 Kaplan-Meier survival analysis Methods 0.000 description 3
239000012097 Lipofectamine 2000 Substances 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
108010089430 Phosphoproteins Proteins 0.000 description 3
102000007982 Phosphoproteins Human genes 0.000 description 3
239000004365 Protease Substances 0.000 description 3
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
229920002472 Starch Polymers 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
102000035181 adaptor proteins Human genes 0.000 description 3
108091005764 adaptor proteins Proteins 0.000 description 3
235000010443 alginic acid Nutrition 0.000 description 3
239000000783 alginic acid Substances 0.000 description 3
229920000615 alginic acid Polymers 0.000 description 3
229960001126 alginic acid Drugs 0.000 description 3
150000004781 alginic acids Chemical class 0.000 description 3
230000003321 amplification Effects 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
210000005013 brain tissue Anatomy 0.000 description 3
229910002092 carbon dioxide Inorganic materials 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
238000007906 compression Methods 0.000 description 3
230000006835 compression Effects 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
239000005547 deoxyribonucleotide Substances 0.000 description 3
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
231100000673 dose–response relationship Toxicity 0.000 description 3
239000008298 dragée Substances 0.000 description 3
229940121647 egfr inhibitor Drugs 0.000 description 3
239000012530 fluid Substances 0.000 description 3
125000000524 functional group Chemical group 0.000 description 3
238000001476 gene delivery Methods 0.000 description 3
238000010353 genetic engineering Methods 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
238000002649 immunization Methods 0.000 description 3
230000003053 immunization Effects 0.000 description 3
238000000099 in vitro assay Methods 0.000 description 3
230000006698 induction Effects 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
235000010355 mannitol Nutrition 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
239000003921 oil Substances 0.000 description 3
235000019198 oils Nutrition 0.000 description 3
238000007911 parenteral administration Methods 0.000 description 3
239000002504 physiological saline solution Substances 0.000 description 3
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
239000001267 polyvinylpyrrolidone Substances 0.000 description 3
229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
239000013641 positive control Substances 0.000 description 3
230000000069 prophylactic effect Effects 0.000 description 3
230000004044 response Effects 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
239000012679 serum free medium Substances 0.000 description 3
150000003384 small molecules Chemical class 0.000 description 3
229960002920 sorbitol Drugs 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
238000013268 sustained release Methods 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
238000013519 translation Methods 0.000 description 3
230000005751 tumor progression Effects 0.000 description 3
241000701447 unidentified baculovirus Species 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 2
DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 2
244000215068 Acacia senegal Species 0.000 description 2
101710186708 Agglutinin Proteins 0.000 description 2
239000012103 Alexa Fluor 488 Substances 0.000 description 2
241000167854 Bourreria succulenta Species 0.000 description 2
101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
241000700198 Cavia Species 0.000 description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
NNJPGOLRFBJNIW-UHFFFAOYSA-N Demecolcine Natural products C1=C(OC)C(=O)C=C2C(NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-UHFFFAOYSA-N 0.000 description 2
239000004338 Dichlorodifluoromethane Substances 0.000 description 2
206010061818 Disease progression Diseases 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241000283086 Equidae Species 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
108091006057 GST-tagged proteins Proteins 0.000 description 2
238000002738 Giemsa staining Methods 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
108010024636 Glutathione Proteins 0.000 description 2
229920000084 Gum arabic Polymers 0.000 description 2
101710146024 Horcolin Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 2
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
239000012741 Laemmli sample buffer Substances 0.000 description 2
101710189395 Lectin Proteins 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
101710179758 Mannose-specific lectin Proteins 0.000 description 2
101710150763 Mannose-specific lectin 1 Proteins 0.000 description 2
101710150745 Mannose-specific lectin 2 Proteins 0.000 description 2
108010021466 Mutant Proteins Proteins 0.000 description 2
102000008300 Mutant Proteins Human genes 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
241000282579 Pan Species 0.000 description 2
241000282520 Papio Species 0.000 description 2
241001494479 Pecora Species 0.000 description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
101800004937 Protein C Proteins 0.000 description 2
102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 2
108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
101800001700 Saposin-D Proteins 0.000 description 2
102400000827 Saposin-D Human genes 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
241000282887 Suidae Species 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
ZKHQWZAMYRWXGA-KNYAHOBESA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] dihydroxyphosphoryl hydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)O[32P](O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KNYAHOBESA-N 0.000 description 2
235000010489 acacia gum Nutrition 0.000 description 2
239000000205 acacia gum Substances 0.000 description 2
239000013543 active substance Substances 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
239000000910 agglutinin Substances 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
239000003708 ampul Substances 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
239000003125 aqueous solvent Substances 0.000 description 2
238000002820 assay format Methods 0.000 description 2
239000011324 bead Substances 0.000 description 2
229960002903 benzyl benzoate Drugs 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
229960004424 carbon dioxide Drugs 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
210000003793 centrosome Anatomy 0.000 description 2
229960005395 cetuximab Drugs 0.000 description 2
235000019693 cherries Nutrition 0.000 description 2
210000000038 chest Anatomy 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
229940110456 cocoa butter Drugs 0.000 description 2
235000019868 cocoa butter Nutrition 0.000 description 2
238000010293 colony formation assay Methods 0.000 description 2
239000007891 compressed tablet Substances 0.000 description 2
238000004590 computer program Methods 0.000 description 2
235000009508 confectionery Nutrition 0.000 description 2
239000013068 control sample Substances 0.000 description 2
238000013270 controlled release Methods 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
210000005220 cytoplasmic tail Anatomy 0.000 description 2
230000034994 death Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
230000001934 delay Effects 0.000 description 2
PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 2
235000019404 dichlorodifluoromethane Nutrition 0.000 description 2
229940042935 dichlorodifluoromethane Drugs 0.000 description 2
229940087091 dichlorotetrafluoroethane Drugs 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
230000005750 disease progression Effects 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
239000008157 edible vegetable oil Substances 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
230000008995 epigenetic change Effects 0.000 description 2
229940082789 erbitux Drugs 0.000 description 2
AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
239000000945 filler Substances 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
235000003599 food sweetener Nutrition 0.000 description 2
XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 2
230000030279 gene silencing Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
239000008103 glucose Substances 0.000 description 2
229960003180 glutathione Drugs 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
230000009422 growth inhibiting effect Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
230000002055 immunohistochemical effect Effects 0.000 description 2
238000003364 immunohistochemistry Methods 0.000 description 2
239000012133 immunoprecipitate Substances 0.000 description 2
239000003018 immunosuppressive agent Substances 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
239000003701 inert diluent Substances 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
230000008595 infiltration Effects 0.000 description 2
238000001764 infiltration Methods 0.000 description 2
238000001361 intraarterial administration Methods 0.000 description 2
239000000644 isotonic solution Substances 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
239000007937 lozenge Substances 0.000 description 2
239000010687 lubricating oil Substances 0.000 description 2
208000037841 lung tumor Diseases 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000003550 marker Substances 0.000 description 2
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
239000003094 microcapsule Substances 0.000 description 2
239000011812 mixed powder Substances 0.000 description 2
239000007932 molded tablet Substances 0.000 description 2
239000003068 molecular probe Substances 0.000 description 2
238000000491 multivariate analysis Methods 0.000 description 2
239000006199 nebulizer Substances 0.000 description 2
230000035407 negative regulation of cell proliferation Effects 0.000 description 2
230000005937 nuclear translocation Effects 0.000 description 2
229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 2
230000035699 permeability Effects 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
229910052698 phosphorus Inorganic materials 0.000 description 2
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
229920000053 polysorbate 80 Polymers 0.000 description 2
229940068968 polysorbate 80 Drugs 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
239000003380 propellant Substances 0.000 description 2
229960000856 protein c Drugs 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000007420 radioactive assay Methods 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
230000001603 reducing effect Effects 0.000 description 2
230000009467 reduction Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000002271 resection Methods 0.000 description 2
238000012552 review Methods 0.000 description 2
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
235000019204 saccharin Nutrition 0.000 description 2
229940081974 saccharin Drugs 0.000 description 2
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
238000005070 sampling Methods 0.000 description 2
230000009863 secondary prevention Effects 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
239000008159 sesame oil Substances 0.000 description 2
235000011803 sesame oil Nutrition 0.000 description 2
239000007974 sodium acetate buffer Substances 0.000 description 2
235000012424 soybean oil Nutrition 0.000 description 2
239000003549 soybean oil Substances 0.000 description 2
230000019130 spindle checkpoint Effects 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
150000005846 sugar alcohols Polymers 0.000 description 2
239000007940 sugar coated tablet Substances 0.000 description 2
239000000829 suppository Substances 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
239000012730 sustained-release form Substances 0.000 description 2
239000003765 sweetening agent Substances 0.000 description 2
230000008961 swelling Effects 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
210000001550 testis Anatomy 0.000 description 2
239000002562 thickening agent Substances 0.000 description 2
238000011200 topical administration Methods 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
235000010487 tragacanth Nutrition 0.000 description 2
239000000196 tragacanth Substances 0.000 description 2
229940116362 tragacanth Drugs 0.000 description 2
239000012096 transfection reagent Substances 0.000 description 2
CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 2
229940029284 trichlorofluoromethane Drugs 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
230000005740 tumor formation Effects 0.000 description 2
231100000588 tumorigenic Toxicity 0.000 description 2
230000000381 tumorigenic effect Effects 0.000 description 2
238000007473 univariate analysis Methods 0.000 description 2
230000003827 upregulation Effects 0.000 description 2
235000015112 vegetable and seed oil Nutrition 0.000 description 2
239000008158 vegetable oil Substances 0.000 description 2
230000035899 viability Effects 0.000 description 2
238000005406 washing Methods 0.000 description 2
239000008215 water for injection Substances 0.000 description 2
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
108020004465 16S ribosomal RNA Proteins 0.000 description 1
HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
MXXGKASZZLDWPV-UHFFFAOYSA-N 5-methylpyrimidine Chemical group CC1=CN=C=N[CH]1 MXXGKASZZLDWPV-UHFFFAOYSA-N 0.000 description 1
LMEHJKJEPRYEEB-UHFFFAOYSA-N 5-prop-1-ynylpyrimidine Chemical compound CC#CC1=CN=CN=C1 LMEHJKJEPRYEEB-UHFFFAOYSA-N 0.000 description 1
108020005075 5S Ribosomal RNA Proteins 0.000 description 1
206010069754 Acquired gene mutation Diseases 0.000 description 1
102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
206010068873 Adenosquamous cell carcinoma Diseases 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
239000012110 Alexa Fluor 594 Substances 0.000 description 1
102000000132 Alpha tubulin Human genes 0.000 description 1
101100278886 Arabidopsis thaliana E2FF gene Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108091032955 Bacterial small RNA Proteins 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
101800004419 Cleaved form Proteins 0.000 description 1
235000019750 Crude protein Nutrition 0.000 description 1
102000007260 Deoxyribonuclease I Human genes 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
241000672609 Escherichia coli BL21 Species 0.000 description 1
108700039887 Essential Genes Proteins 0.000 description 1
241000195619 Euglena gracilis Species 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
108010074860 Factor Xa Proteins 0.000 description 1
DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
206010053759 Growth retardation Diseases 0.000 description 1
102100021888 Helix-loop-helix protein 1 Human genes 0.000 description 1
101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 1
101000897691 Homo sapiens Helix-loop-helix protein 1 Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
208000007433 Lymphatic Metastasis Diseases 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
238000000585 Mann–Whitney U test Methods 0.000 description 1
235000006679 Mentha X verticillata Nutrition 0.000 description 1
244000246386 Mentha pulegium Species 0.000 description 1
235000016257 Mentha pulegium Nutrition 0.000 description 1
235000002899 Mentha suaveolens Nutrition 0.000 description 1
235000004357 Mentha x piperita Nutrition 0.000 description 1
235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
206010059282 Metastases to central nervous system Diseases 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
108091029480 NONCODE Proteins 0.000 description 1
206010061309 Neoplasm progression Diseases 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
108091092724 Noncoding DNA Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
229930012538 Paclitaxel Natural products 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
108010056751 Phospholipase C gamma Proteins 0.000 description 1
102000004422 Phospholipase C gamma Human genes 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
101000622060 Photinus pyralis Luciferin 4-monooxygenase Proteins 0.000 description 1
HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
239000012083 RIPA buffer Substances 0.000 description 1
108091034057 RNA (poly(A)) Proteins 0.000 description 1
102000014450 RNA Polymerase III Human genes 0.000 description 1
108010078067 RNA Polymerase III Proteins 0.000 description 1
238000011530 RNeasy Mini Kit Methods 0.000 description 1
238000010240 RT-PCR analysis Methods 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
241000235343 Saccharomycetales Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
108020004688 Small Nuclear RNA Proteins 0.000 description 1
102000039471 Small Nuclear RNA Human genes 0.000 description 1
208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
108700005078 Synthetic Genes Proteins 0.000 description 1
244000247617 Teramnus labialis var. labialis Species 0.000 description 1
208000024313 Testicular Neoplasms Diseases 0.000 description 1
206010057644 Testis cancer Diseases 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
108090000704 Tubulin Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
201000008395 adenosquamous carcinoma Diseases 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
208000037842 advanced-stage tumor Diseases 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
229940040563 agaric acid Drugs 0.000 description 1
210000001552 airway epithelial cell Anatomy 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
238000007844 allele-specific PCR Methods 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
238000011319 anticancer therapy Methods 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
239000012131 assay buffer Substances 0.000 description 1
239000000305 astragalus gummifer gum Substances 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
230000009702 cancer cell proliferation Effects 0.000 description 1
230000005907 cancer growth Effects 0.000 description 1
239000012830 cancer therapeutic Substances 0.000 description 1
229940022399 cancer vaccine Drugs 0.000 description 1
238000009566 cancer vaccine Methods 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000032823 cell division Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000030570 cellular localization Effects 0.000 description 1
230000004700 cellular uptake Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
238000010382 chemical cross-linking Methods 0.000 description 1
210000003763 chloroplast Anatomy 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
239000003593 chromogenic compound Substances 0.000 description 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
229960004316 cisplatin Drugs 0.000 description 1
238000000749 co-immunoprecipitation Methods 0.000 description 1
230000003081 coactivator Effects 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
229940099112 cornstarch Drugs 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
230000009274 differential gene expression Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
229960003668 docetaxel Drugs 0.000 description 1
230000002222 downregulating effect Effects 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
238000009509 drug development Methods 0.000 description 1
239000003596 drug target Substances 0.000 description 1
230000000431 effect on proliferation Effects 0.000 description 1
238000004945 emulsification Methods 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
238000007459 endoscopic retrograde cholangiopancreatography Methods 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000005755 formation reaction Methods 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
229940014259 gelatin Drugs 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 1
229960005277 gemcitabine Drugs 0.000 description 1
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
238000005469 granulation Methods 0.000 description 1
230000003179 granulation Effects 0.000 description 1
238000000227 grinding Methods 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
230000009036 growth inhibition Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
201000000459 head and neck squamous cell carcinoma Diseases 0.000 description 1
MAHXCOMHJBHBGO-RTKIROINSA-N hematoxin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H](OC)C11C=CC(=O)C(O)=C1OC2 MAHXCOMHJBHBGO-RTKIROINSA-N 0.000 description 1
XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000012203 high throughput assay Methods 0.000 description 1
238000013537 high throughput screening Methods 0.000 description 1
150000002411 histidines Chemical class 0.000 description 1
235000001050 hortel pimenta Nutrition 0.000 description 1
102000045108 human EGFR Human genes 0.000 description 1
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
238000000370 laser capture micro-dissection Methods 0.000 description 1
238000001001 laser micro-dissection Methods 0.000 description 1
230000003902 lesion Effects 0.000 description 1
125000001909 leucine group Chemical class [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
244000144972 livestock Species 0.000 description 1
230000004807 localization Effects 0.000 description 1
201000005243 lung squamous cell carcinoma Diseases 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
238000012775 microarray technology Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
230000000394 mitotic effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
102000035118 modified proteins Human genes 0.000 description 1
108091005573 modified proteins Proteins 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000002534 molecular mass spectrometry Methods 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
239000013642 negative control Substances 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
238000011580 nude mouse model Methods 0.000 description 1
238000013392 nude mouse xenograft model Methods 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
230000004650 oncogenic pathway Effects 0.000 description 1
102000027450 oncoproteins Human genes 0.000 description 1
108091008819 oncoproteins Proteins 0.000 description 1
238000005457 optimization Methods 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
229960001592 paclitaxel Drugs 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
230000011340 peptidyl-tyrosine autophosphorylation Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
229960003531 phenolsulfonphthalein Drugs 0.000 description 1
108091005981 phosphorylated proteins Proteins 0.000 description 1
239000000419 plant extract Substances 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
229940116317 potato starch Drugs 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000009862 primary prevention Effects 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960001309 procaine hydrochloride Drugs 0.000 description 1
229940043274 prophylactic drug Drugs 0.000 description 1
238000002331 protein detection Methods 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000011160 research Methods 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
108010008790 ribosomal phosphoprotein P1 Proteins 0.000 description 1
229940100486 rice starch Drugs 0.000 description 1
238000012502 risk assessment Methods 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
239000013605 shuttle vector Substances 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
230000000391 smoking effect Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000001433 sodium tartrate Substances 0.000 description 1
229960002167 sodium tartrate Drugs 0.000 description 1
235000011004 sodium tartrates Nutrition 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
230000037439 somatic mutation Effects 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
230000003068 static effect Effects 0.000 description 1
239000008174 sterile solution Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
125000004434 sulfur atom Chemical group 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
238000010846 tandem mass spectrometry analysis Methods 0.000 description 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
201000003120 testicular cancer Diseases 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
230000005748 tumor development Effects 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
238000012795 verification Methods 0.000 description 1
GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 description 1
229960002066 vinorelbine Drugs 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
229940100445 wheat starch Drugs 0.000 description 1
239000009637 wintergreen oil Substances 0.000 description 1